Development of sofosbuvir for the treatment of hepatitis C virus infection-Reference-Cited by-同舟云学术

Development of sofosbuvir for the treatment of hepatitis C virus infection

Published:2015-07-31 Issue:1 Volume:1358 Page:56-67
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Ann. N.Y. Acad. Sci.

Author:

Lawitz Eric¹,Jacobson Ira M.²,Nelson David R.³,Zeuzem Stefan⁴,Sulkowski Mark S.⁵,Esteban Rafael⁶,Brainard Diana⁷,McNally John⁷,Symonds William T.⁷,McHutchison John G.⁷,Dieterich Douglas⁸,Gane Edward⁹

Affiliation:

1. Texas Liver Institute; University of Texas Health Science Center; San Antonio Texas

2. Icahn School of Medicine at Mount Sinai; New York New York

3. University of Florida; Gainesville Florida

4. Medical Center, Johann Wolfgang Goethe University; Frankfurt am Main Germany

5. Johns Hopkins University School of Medicine; Baltimore Maryland

6. Hospital Universitario Val d'Hebron; Barcelona Spain

7. Gilead Sciences; Foster City California

8. Mount Sinai School of Medicine; New York New York

9. Auckland City Hospital; Auckland New Zealand

Funder

Gilead Sciences

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/nyas.12832/fullpdf

Reference44 articles.

1. Centers for Disease Control and Prevention 2011 Viral hepatitis surveillance, United States, 2009 http://www.cdc.gov/hepatitis/Statistics/2009Surveillance/index.htm

2. EASL clinical practice guidelines: management of hepatitis C virus infection;Craxi;J. Hepatol.,2011

3. Diagnosis, management, and treatment of hepatitis C: an update;Ghany;Hepatology,2009

4. Centers for Disease Control and Prevention 2015 Viral hepatitis surveillance, United States, 2012 http://www.cdc.gov/hepatitis/Statistics/2012Surveillance/index.htm

5. Hepatitis C virus directly acting antivirals: current developments with NS3/4A HCV serine protease inhibitors;Naggie;J. Antimicrob. Chemother.,2010

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shaping the future of antiviral Treatment: Spotlight on Nucleobase-Containing drugs and their revolutionary impact;Bioorganic Chemistry;2024-03

2. Hepatitis C: The Story of a Long Journey through First, Second, and Third Generation NS3/4A Peptidomimetic Inhibitors. What Did We Learn?;Journal of Medicinal Chemistry;2024-01-05

3. Exploring the Potential of Microbial Biomolecules in Advancing Human Health and Environmental Sustainability;Industrial Microbiology and Biotechnology;2024

4. Genetic and pharmacological perturbation of hepatitis-C virus entry;Current Opinion in Virology;2023-10

5. Analytical and Bioanalytical Methods for the Quantification of the Nucleotide Polymerase Inhibitor - Sofosbuvir: A Critical Review (2015-2021);Current Pharmaceutical Analysis;2023-01